SIRT5 impairs aggregation and activation of the signaling adaptor MAVS through catalyzing lysine desuccinylation

EMBO J. 2020 Jun 2;39(11):e103285. doi: 10.15252/embj.2019103285. Epub 2020 Apr 17.

Abstract

RLR-mediated type I IFN production plays a pivotal role in innate antiviral immune responses, where the signaling adaptor MAVS is a critical determinant. Here, we show that MAVS is a physiological substrate of SIRT5. Moreover, MAVS is succinylated upon viral challenge, and SIRT5 catalyzes desuccinylation of MAVS. Mass spectrometric analysis indicated that Lysine 7 of MAVS is succinylated. SIRT5-catalyzed desuccinylation of MAVS at Lysine 7 diminishes the formation of MAVS aggregation after viral infection, resulting in the inhibition of MAVS activation and leading to the impairment of type I IFN production and antiviral gene expression. However, the enzyme-deficient mutant of SIRT5 (SIRT5-H158Y) loses its suppressive role on MAVS activation. Furthermore, we show that Sirt5-deficient mice are resistant to viral infection. Our study reveals the critical role of SIRT5 in limiting RLR signaling through desuccinylating MAVS.

Keywords: MAVS; SIRT5; desuccinylation; innate immunity; viral infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / metabolism*
  • Amino Acid Substitution
  • Animals
  • Gene Expression Regulation
  • HCT116 Cells
  • HEK293 Cells
  • Humans
  • Interferon Type I / biosynthesis
  • Interferon Type I / genetics
  • Mice
  • Mice, Knockout
  • Mutation, Missense
  • Protein Aggregates*
  • Sirtuins / genetics
  • Sirtuins / metabolism*

Substances

  • Adaptor Proteins, Signal Transducing
  • IPS-1 protein, mouse
  • Interferon Type I
  • MAVS protein, human
  • Protein Aggregates
  • SIRT5 protein, mouse
  • SIRT5 protein, human
  • Sirtuins